GNC Beyond Raw Refine
Natural health product licensed in Canada
- Licence holder
- GNC Canada Holdings ULC
- NPN or DIN-HM
- 80039496
- Status
- Inactive licence
- Licence date
- 4 February 2013
- Revision date
- 7 March 2014
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
- Dose déclarée au-delà d'une limite
Potassium: up to 99 mg a day according to the dosing instructions published by Health Canada (3 unités posologiques par jour au plus, pour les adultes), above the maximum dose of 80 mg set in France for a food supplement (2006 Order, not revised since November 2006).
arrêté du 9 mai 2006, annexe III. French orders of 9 May 2006 and 14 November 2006 as published in the Official Journal (maximum daily doses), retrieved 21 October 2026.
- Conditions légales
Contains tea (Camellia sinensis). Green tea extracts must provide less than 800 mg of epigallocatechin-3-gallate per daily portion, with mandatory warnings.
annexe III, partie B (règlement (UE) 2022/2340). Regulation (EC) No 1925/2006, latest consolidated version, retrieved 21 October 2026.
- Conditions légales
Salix alba L.: L'étiquetage doit comporter un avertissement déconseillant l'emploi aux personnes souffrant d'allergie aux dérivés salicylés.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
- Conditions légales
Camellia sinensis (L.) Kuntze: Seules sont admises la poudre issue du broyage des feuilles et les préparations obtenues à partir des solvants suivants : l'eau, l'alcool à 25 % (v/v), ainsi que les solvants autorisés pour la décaféination ou la suppression des matières irritantes et amères. Les recommandations d'emploi ne doivent pas conduire à une ingestion quotidienne d'EGCG supérieure à 300 mg. L'étiquetage doit comporter des avertissements déconseillant leur prise en dehors des repas, ainsi que leur consommation par les enfants, les adolescents, les femmes enceintes ou allaitantes.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Cinnamomum aromaticum Source : Cinnamomum aromaticum - Écorce (tige) | 16.6 mg | Not calculated |
| Salix alba Source : Écorce de racine Potency : 15 % Salcin | 40 mg | Not calculated |
| Salix alba Source : Salix alba Potency : 15 % Salcin | 40 mg | Not calculated |
| 3-Pyridinecarboxamide Source : Niacinamide | 6.6 mg | Not calculated |
| 1,3,7-Triméthylxanthine | 40 mg | Not calculated |
| Zinc Source : Produit de chélation de zinc et de protéine végétale hydrolysée (PVH) | 5 mg | 15,000 µg |
| Niacine Source : Niacine | 6.6 mg | Not calculated |
| Potassium Source : Chlorure de potassium | 33 mg | 99,000 µg |
| Vitis vinifera Source : Vitis vinifera - Graine Extraction ratio : 1:1 Dry plant equivalent : 8.3 mg Potency : 85 % Proanthocyanidins | 8.3 mg | Not calculated |
| Capsicum annuum Source : Capsicum annuum - fruit Extraction ratio : 10:1 Dry plant equivalent : 111 mg | 11.1 mg | Not calculated |
| Magnésium Source : Aspartate de magnésium | 5.6 mg | 16,800 µg |
| 3,3',4',5,7-Pentahydroxyflavone Source : Styphnolobium japonicum - Bourgeon floral | 33.3 mg | Not calculated |
| 3,3',4',5,7-Pentahydroxyflavone Source : Quercétine | 33.3 mg | Not calculated |
| 5-Hydroxy-L-tryptophane Source : Griffonia simplicifolia, graine | 33.3 mg | Not calculated |
| 5-Hydroxy-L-tryptophane Source : 5-HTP | 33.3 mg | Not calculated |
| Camellia sinensis Source : Camellia sinensis - feuille Extraction ratio : 1:1 Dry plant equivalent : 166.5 mg Potency : 30 % Epigallocatechin 3-gallate | 166.5 mg | Not calculated |
| Camellia sinensis Source : Camellia sinensis - feuille Potency : 15 % Caffeine | Not specified | Not calculated |
Non-medicinal ingredients
Laque d'aluminium jaune FD&C No. 5, Extrait de peau de raisin, Dioxyde de titanium, Chlorure de sodium, Maltodextrine, Laque d'aluminium jaune FD&C No. 6, Stéarate de magnésium, Gélatine
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 3 Capsule | 1 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
To be used with a program of reduced intake of dietary calories and increased physical activity (if possible) to help in weight management. A factor in the maintenance of good health. Helps the body to metabolize carbohydrates, fats and protein. Helps in tissue formation. Helps to maintain healthy skin. Helps in the development and maintenance of bones, cartilage, teeth and gums. Helps in connective tissue formation. Helps in wound healing. An antioxidant for the maintenance of good health. Helps to prevent Vitamin C deficiency. Helps (temporarily) to promote alertness and wakefulness, and to enhance cognitive performance. Helps (temporarily) to relieve fatigue, to promote endurance, and to enhance motor performance. Helps to maintain immune function.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 80039496
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
List recorded in 2014. Photograph the packaging to check whether it has changed. Photograph the packaging